Sun Pharmaceutical’s subsidiary buys stake in US-based company
DSIJ Intelligence / 09 Aug 2017
Drug maker Sun Pharmaceutical Industries has acquired, through its subsidiary, 15.9% stake in US-based Krystal Biotech Inc., a biopharmaceutical company.
Drug maker Sun Pharmaceutical Industries has acquired, through its subsidiary, 15.9% stake in US-based Krystal Biotech Inc., a biopharmaceutical company.
One of the wholly-owned subsidiaries of the company has agreed to make this acquisition by way of allotment to it 2,03,135 Series A Preferred Stock (equivalent to 15.91% fully diluted equity stake on conversion) of Krystal Biotech Inc., United States of America, said Sun Pharma in a BSE filing on Tuesday post market hours. Krystal Biotech Inc. develops advance gene therapy for treatment of patients suffering from rare debilitating disorders.
Meanwhile, Sun Pharmaceutical Industries was trading at Rs 480, down by Rs 20.40 or 4.08% as at 0921 hours on Wednesday, on the BSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.